ChromaDex

ChromaDex combines unsurpassed reference standards, state-of-the-art analytical testing, and authoritative source consulting with scientifically-proven ingredients to improve health and enhance life for all. We’re publicly traded, customer-centric, and health-focused with one goal in mind—create innovative discoveries every day that promote wellness and quality of life.
Type
Public
HQ
Irvine, US
Founded
1999
Size (employees)
80 (est)
ChromaDex was founded in 1999 and is headquartered in Irvine, US

Key People at ChromaDex

Frank L.  Jaksch Jr.

Frank L. Jaksch Jr.

Chief Executive Officer & Co-Founder

ChromaDex Office Locations

ChromaDex has an office in Irvine
Irvine, US (HQ)
g 10005 Muirlands Blvd

ChromaDex Data and Metrics

ChromaDex Financial Metrics

ChromaDex's revenue was reported to be $4.4 m in Q1, 2018
USD

Revenue (Q1, 2018)

4.4 m

Gross profit (Q1, 2018)

1.8 m

Gross profit margin (Q1, 2018), %

39%

Net income (Q1, 2018)

(1.9 m)

EBIT (Q1, 2018)

(1.9 m)

Market capitalization (21-Sep-2017)

181.1 m

Cash (01-Apr-2017)

1.2 m
ChromaDex's current market capitalization is $181.1 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

10.2 m15.3 m22 m26.8 m

Revenue growth, %

51%44%22%

Cost of goods sold

7 m10 m13.5 m14.9 m

Gross profit

3.1 m5.3 m8.5 m11.9 m
USDQ2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

3.9 m4.1 m5.3 m6.1 m6.3 m7.3 m8.8 m5 m4.4 m

Cost of goods sold

2.5 m2.6 m3.3 m3.6 m3.8 m3.9 m4.7 m3 m2.7 m

Gross profit

1.4 m1.5 m1.9 m2.5 m2.5 m3.5 m4.1 m2 m1.8 m

Gross profit Margin, %

36%37%37%40%39%47%47%41%39%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.3 m4 m5.5 m1.6 m

Inventories

2.2 m3.7 m8.2 m7.9 m

Current Assets

5.8 m9.9 m16.5 m15.7 m

Total Assets

9 m11.6 m18.7 m19.8 m
USDQ2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

1.3 m1.2 m3.2 m5.7 m4.7 m3 m3.4 m2.3 m1.2 m

Inventories

2.9 m2.3 m3.2 m3.1 m4.2 m6.7 m4.5 m6.3 m8.9 m

Current Assets

6.6 m6.3 m9.1 m12.3 m13 m14.4 m15.2 m15.5 m15.6 m

Total Assets

8.9 m8.7 m11 m14.2 m15 m16.5 m17.8 m18.8 m21.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(4.4 m)(5.4 m)(2.8 m)(2.9 m)

Inventories

(466.4 k)(1.5 m)(4.4 m)240.9 k

Accounts Payable

(1.6 m)2.2 m2.8 m(245.7 k)

Cash From Operating Activities

(3.9 m)(2.6 m)(2.1 m)(2.9 m)
USDQ2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

(1.7 m)(659.7 k)(1 m)(315.2 k)(3.7 k)255.6 k(82.7 k)(954.4 k)(1.9 m)

Inventories

2.9 m2.3 m3.2 m3.1 m4.2 m6.7 m4.5 m6.3 m8.9 m

Accounts Payable

2.8 m2.3 m2.6 m3.1 m3.6 m2.9 m2.3 m4.1 m7.9 m
Y, 2017

Financial Leverage

2.2 x
Show all financial metrics

ChromaDex Market Value History

Traffic Overview of ChromaDex

ChromaDex Online and Social Media Presence

ChromaDex News and Updates

A new lawsuit alleges anti-aging startup Elysium Health hasn’t paid its sole supplier

 Chromadex, the sole supplier of anti-aging startup Elysium Health‘s two main product ingredients pterostilbene and Nicotinamide Riboside (NR), is suing the startup for failure to make payments on those ingredients and for breach of a trademark and royalties agreement. According to a document on Chr…

The Weird Business Behind a Trendy “Anti-Aging” Pill

Elysium has attracted press because of its scientific stars, but it’s ChromaDex that is quietly blurring the boundary between drug and supplement. The post The Weird Business Behind a Trendy "Anti-Aging" Pill appeared first on WIRED.

ChromaDex Company Life and Culture

You may also be interested in